hydroxychloroquine has been researched along with Hepatic Porphyria in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Excerpt | Relevance | Reference |
---|---|---|
"This review focuses on hepatic porphyrias, which include acute intermittent porphyria (AIP), variegate porphyria (VP), hereditary coproporphyria (HCP), aminolevulinic acid dehydratase deficiency porphyria (ADP), and porphyria cutanea tarda (PCT)." | 2.53 | Hepatic porphyria: A narrative review. ( Arora, S; Kodali, S; Singal, AK; Young, S, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arora, S | 1 |
Young, S | 1 |
Kodali, S | 1 |
Singal, AK | 1 |
1 review available for hydroxychloroquine and Hepatic Porphyria
Article | Year |
---|---|
Hepatic porphyria: A narrative review.
Topics: Acute Disease; Alcoholism; Biomarkers; Glucose; Hemin; Hemochromatosis; Hepatitis C; HIV Infections; | 2016 |